Divis Laboratories Sees Significant Open Interest Surge Amidst Market Dynamics Shift
Divis Laboratories Ltd has reported a notable rise in open interest, reaching 56,109 contracts, alongside a trading volume of 32,255 contracts. The company, with a market capitalization of Rs 1,77,887 crore, has faced recent performance challenges, including a decline in delivery volume and underperformance relative to its sector.
Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant increase in open interest today. The latest open interest stands at 56,109 contracts, marking an increase of 8,833 contracts or 18.68% from the previous open interest of 47,276. This uptick coincides with a trading volume of 32,255 contracts, reflecting active market engagement.In terms of financial metrics, Divis Laboratories has a market capitalization of Rs 1,77,887 crore, categorizing it as a large-cap stock. However, the stock has underperformed its sector by 0.58% today, continuing a trend of decline with a 0.95% drop over the last three days. The stock's current price is below its 5-day, 20-day, and 50-day moving averages, although it remains above the 100-day and 200-day moving averages.
Additionally, the stock has seen a decrease in delivery volume, which has fallen by 22.69% compared to the 5-day average. Despite these challenges, the liquidity remains adequate for trades up to Rs 2.74 crore, based on 2% of the 5-day average traded value. Overall, the notable increase in open interest highlights a shift in market dynamics for Divis Laboratories, amidst a backdrop of recent performance trends.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
